Los factores de transcripción NR4A limitan la función de las células T CAR en los tumores sólidos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Ver abstracta en PubMed
Resumen
Este resumen es generado por máquina.Las células T receptoras del antígeno quimérico (CAR) dirigidas a tumores sólidos se vuelven disfuncionales debido a los factores de transcripción NR4A. La inhibición de estos factores NR4A puede restaurar la función de las células CAR T para mejorar la inmunoterapia contra el cáncer.
Área De La Ciencia
- Inmunología
- Biología del cáncer
- Biología molecular
Sus Antecedentes
- Las células T del receptor del antígeno quimérico (CAR) son efectivas contra las neoplasias de células B, pero menos contra los tumores sólidos.
- La disfunción de las células CAR T en tumores sólidos está relacionada con la estimulación crónica del antígeno y la regulación al alza de los receptores inhibidores.
- Este estado de hiporrespuesta implica vías específicas de activación del factor de transcripción.
Objetivo Del Estudio
- Investigar los mecanismos de la hiporrespuesta de las células CAR T en tumores sólidos.
- Identificar los actores moleculares clave involucrados en la disfunción de las células T CAR.
- Explorar nuevos objetivos terapéuticos para mejorar la eficacia de las células CAR T en la inmunoterapia contra el cáncer.
Principales Métodos
- Transferencia de células T CAR humanas reactivas a CD19 en modelos de ratón portadores de tumores CD19+.
- Análisis de la expresión génica y la accesibilidad de la cromatina en los linfocitos infiltrantes tumorales (TIL).
- Generación y evaluación de células T CAR triple knockout del factor de transcripción NR4A.
Principales Resultados
- Las células T CAR CD8+ y las TIL endógenas en los tumores mostraron perfiles de expresión génica similares vinculados a los factores de transcripción NR4A.
- Los factores de transcripción NR4A fueron altamente expresados en las células T de pacientes con cáncer e infecciones crónicas.
- Las células T CAR triple knockout NR4A promovieron la regresión tumoral, prolongaron la supervivencia y exhibieron fenotipos de células T efectoras.
Conclusiones
- Los factores de transcripción NR4A juegan un papel crítico en la hiporrespuesta de las células T.
- La inhibición de NR4A representa una estrategia prometedora para superar la disfunción de las células CAR T en el cáncer.
- La orientación de los factores NR4A podría mejorar la eficacia de la terapia con células T CAR para los tumores sólidos.
Contact us Si estos videos no son relevantes.
Contact us Si estos videos no son relevantes.
Videos de Conceptos Relacionados
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...